Search interest connects nattokinase to headaches in two very different ways: some users report mild, temporary sensations when starting the supplement, and separately, severe or unusual headache is listed as a warning sign of a rare but serious bleeding complication tied to nattokinase’s blood-thinning effect. These are not the same thing, and confusing them matters. Here is what the actual trial data and safety literature show.
Key Takeaways
- In the Nattokinase Atherothrombotic Prevention Study, a randomized trial registered on ClinicalTrials.gov, headache was not reported more often in the nattokinase group than in the placebo group, providing no trial evidence [1] that nattokinase itself commonly causes headaches.
- No dedicated clinical study has tested nattokinase specifically as a treatment for migraine, tension headache, or vascular headache; any such claim is not supported by controlled research.
- Some anecdotal user reports describe brief, mild head or ear sensations in the first days of use, which are self-reported and not confirmed by clinical data.
- Severe, sudden, or unusually intense headache, along with vision changes or confusion, is flagged in safety literature as a potential warning sign of intracranial bleeding, a rare but serious risk associated with nattokinase’s fibrinolytic and antiplatelet activity.
- Anyone taking nattokinase who experiences a severe or unusual headache, especially alongside other neurological symptoms, should treat it as a medical warning sign and seek care rather than waiting it out.
This post contains affiliate links. As an Amazon Associate, NattokinaseHub earns from qualifying purchases at no extra cost to you.
What the Clinical Trial Data Actually Shows
The strongest available data point comes from the Nattokinase Atherothrombotic Prevention Study, a randomized controlled trial registered on ClinicalTrials.gov (NCT02080520) that tracked adverse events in both a nattokinase group and a placebo group for up to three years[1]. Headache was reported in 0 of 132 participants in the nattokinase group, compared to 2 of 133 participants (1.5 percent) in the placebo group[2]. In other words, the trial recorded no more headaches on nattokinase than on placebo. With so few events in either group that is weak evidence either way, but it gives no sign that headache is a common side effect [1].
No Trial Has Tested Nattokinase as a Headache Treatment
On the other side of the question, no dedicated clinical trial has tested nattokinase specifically as a treatment for migraine, tension headache, or vascular headache. Nattokinase’s research base is mostly small blood pressure trials, lab work on blood viscosity and clotting, and animal studies, with no headache treatment trials [4][5][1][6]. If you encounter claims that nattokinase treats migraines or vascular headaches through improved circulation, treat that as an untested extrapolation from its cardiovascular research rather than a demonstrated benefit.
Research note: In a 2021 case report of a woman taking nattokinase who bled into the abdomen, clotting tests on admission were near normal (INR 1.3, aPTT 21.5), so routine tests did not flag the bleeding tendency [7].
What Anecdotal Reports Describe
Some user-submitted, non-clinical accounts describe brief, mild sensations when starting nattokinase, including temporary ringing or pressure sensations near the ears, or mild temple discomfort in the first days of use, which some attribute informally to improved blood flow. These are self-reported, uncontrolled anecdotes rather than data from a monitored trial, and they should be weighted accordingly. If a first-time user experiences a mild, brief, self-resolving sensation, it is reasonable context to be aware of, but it is not evidence of a consistent or expected effect, and anecdote should never override the actual documented safety guidance below.
The Genuinely Important Safety Signal
This is the part of the topic that matters most from a safety standpoint, and it has nothing to do with mild anecdotal reports. Because nattokinase has real fibrinolytic and antiplatelet activity, standard guidance is that severe, sudden-onset, or unusually intense headache, particularly when accompanied by vision changes, confusion, weakness, or difficulty speaking, can be a warning sign of intracranial bleeding. That risk is not only theoretical: a published case report describes an acute cerebellar hemorrhage in a patient taking aspirin for secondary stroke prevention who had added nattokinase 400 mg daily for seven days, with multiple cerebral microbleeds also visible on MRI. The authors suggest nattokinase may raise the risk of intracerebral hemorrhage in people with bleeding-prone small vessel disease who are also taking another antithrombotic drug[3]. This is a rare event, but it is a documented risk category for any compound with meaningful blood-thinning activity, and it is the reason nattokinase carries explicit warnings around use alongside anticoagulant medications, before surgery, and in anyone with an existing bleeding disorder or history of hemorrhagic stroke.
How to Tell the Difference
A brief, mild sensation in the first day or two of starting a new supplement is a very different clinical picture from a sudden, severe, or unusual headache accompanied by neurological symptoms. The second pattern is a medical emergency warning sign regardless of what supplement someone is taking, and it should prompt immediate medical evaluation, not a wait-and-see approach. This distinction matters more for people already taking blood thinners, people with a bleeding disorder, and anyone recently prescribed nattokinase alongside another anticoagulant or antiplatelet medication, where the combined bleeding risk is elevated.
Frequently Asked Questions
Does nattokinase cause headaches?
The best available trial data shows no elevated headache rate with nattokinase compared to placebo; if anything, headache was not reported more often in the nattokinase group in one randomized trial [1]. Some anecdotal, non-clinical reports describe mild, brief sensations, but this is not confirmed by controlled data.
Can nattokinase treat migraines?
No clinical trial has tested nattokinase as a migraine or headache treatment. Any claim to this effect is an untested extrapolation from its unrelated cardiovascular research, not an established benefit.
When is a headache while taking nattokinase a medical emergency?
A sudden, severe, or unusual headache, especially with vision changes, confusion, weakness, or trouble speaking, should be treated as a possible sign of bleeding and requires immediate medical attention, given nattokinase’s blood-thinning activity.
References
- Hodis HN, et al. Nattokinase atherothrombotic prevention study: A randomized controlled trial. Clin Hemorheol Microcirc (2021). PMID 33843667
- Nattokinase Atherothrombotic Prevention Study (NAPS), adverse events table, posted results. ClinicalTrials.gov. NCT02080520
- Chang YY, et al. Cerebellar hemorrhage provoked by combined use of nattokinase and aspirin in a patient with cerebral microbleeds. Intern Med (2008). PMID 18310985
- Kim JY et al. Effects of nattokinase on blood pressure: a randomized, controlled trial. Hypertension research : official journal of the Japanese Society of Hypertension (2008). PMID 18971533
- Jensen GS et al. Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial. Integrated blood pressure control (2016). PMID 27785095
- Eszter Pais et al. Effects of nattokinase, a pro-fibrinolytic enzyme, on red blood cell aggregation and whole blood viscosity. PubMed (2006). PMID 16899918
- Lintu Ramachandran et al. Nattokinase-Associated Hemoperitoneum in an Elderly Woman. Cureus (2021). PMID 35003944
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Seek immediate medical attention for any sudden, severe headache, especially alongside vision changes, confusion, or weakness. Always talk to your doctor before starting nattokinase, especially if you take blood thinners or have an upcoming surgery.
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
